erastin,
ERASTIN,
571203-78-6,
2-[1-[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone,
MFCD09837984,
CHEMBL401989,
SCHEMBL4457820,
Erastin, >=98% (HPLC),
CHEBI:94287,
CTK1G7671,
AOB6043,
DTXSID80458949,
EX-A295,
HMS3653K21,
BCP27907,
2400AH,
BDBM50376126,
s7242,
AKOS025147365,
CS-1675,
SB19588,
2-[1-[4-[2-(4-chlorophenoxy)acetyl]piperazin-1-yl]ethyl]-3-(2-ethoxyphenyl)quinazolin-4-one,
KS-0000002U,
NCGC00351608-10,
NCGC00351608-14,
AK473987,
BC600677,
DA-42059,
HY-15763,
QC-11375,
AB0098412,
FT-0700333,
SW208651-2,
C21478,
BRD-A25004090-001-01-9,
BRD-A25004090-001-02-7,
BRD-A25004090-001-06-8,
2-(1-(4-(2-(4-chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4(3H)-one,
4(3H)-Quinazolinone, 2-[1-[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-,
C30H31ClN4O4,
ACN-036841,
CID11214940,
2-[1-[4-[2- acetyl]-1-piperazinyl]ethyl]-3- -4 -Quinazolinone,